N/A
Completed N=1,120
ION US Post-Approval Study
Source: ClinicalTrials.gov NCT01422889 ↗Enrolled (actual)
1,120
Serious AEs
29.2%
Results posted
Mar 2015
Primary outcomePrimary: Cardiac Death or Myocardial Infarction (CD/MI) — 2.2 percentage of paricipants
Summary
The purpose of this study is to compile real-world clinical outcomes data for the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System in routine clinical practice.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Cardiac Death or Myocardial Infarction (CD/MI) |
2.2 | — |
| SECONDARY Stent Thrombosis |
2.6 | — |
Eligibility Criteria
Inclusion Criteria
Consented subjects receiving one or more ION(TM)Coronary Stents
Exclusion Criteria
Subjects not clinically indicated to receive an ION (TM)Coronary Stent
Data sourced from ClinicalTrials.gov (NCT01422889). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.